Fig. 2From: Preclinical evaluation of the theranostic potential of 89Zr/177Lu-labeled anti-TROP-2 antibody in triple-negative breast cancer modelMolecular structure design and identification of NY003. A Structural sketch of the full-length antibody NY003. B SDS-PAGE analysis result of NY003. C Binding affinity via ELISABack to article page